MedTrace Logo

A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety

NCT05684640 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-01-27

No results posted yet for this study

Summary

This is a single and multiple dose food effect study of rodatristat ethyl in healthy subjects

Conditions

  • Healthy

Interventions

DRUG

Rodatristat Ethyl

Tablets, Oral, 600mg, QD

DRUG

Placebo

Tablets, Oral, 0mg, BID

Sponsors & Collaborators

  • PPD Development, LP

    collaborator INDUSTRY

  • Altavant Sciences GmbH

    lead INDUSTRY

Principal Investigators

  • Thomas Hunt, MD · PPD Development, LP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2023-01-17
Completion
2023-01-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05684640 on ClinicalTrials.gov